Technical Analysis

Stock query: Canara Bank paused above a key base

Yoganand D | Updated on March 22, 2020 Published on March 22, 2020

Here are the answers to readers’ queries on the performance of their stock holdings.

I brought Canara Bank shares at ₹217. Should I sell or hold?

KBD Prasaad

Canara Bank (₹96.1): The stock of Canara Bank has been in a long-term downtrend since recording a new high at ₹820 in late 2010. Both the medium- as well as the short-term trend is down for the stock. In early March, it decisively breached a key long-term support at around ₹150 and continued to trend downwards. After registering a multi-year low at ₹83 in the week before, the stock started to move sideways.

The daily relative strength index (RSI) is showing positive divergence, indicating possible trend-reversal in the short term. A strong rally above the immediate resistance level of ₹110 can take the stock higher to ₹127 and then to ₹140. Only a decisive rally above ₹150 will alter the short-term downtrend and take the stock higher to ₹170 and then to ₹185. The next vital resistance is at ₹200.

On the downside, a fall below the immediate support level of ₹90 can pull the stock down to ₹83 and then to ₹75.

The next supports are at ₹70 and ₹63. You can consider averaging the stock in declines with a stop-loss at ₹80. Consider booking profits if the stock struggles to move beyond ₹150 levels.

What are the prospects of Lupin and Aurobindo Pharma?

Pradeep Kabra

Lupin (₹641.6): The stock of Lupin is in a downtrend across all time-frames — long, medium and short term. After recording a multi-year low at ₹505 on March 13, the stock formed a hammer candlestick pattern in the daily chart, which is a bullish reversal pattern. It has been trending upwards since then.

There has been an increase in daily volume over the past two weeks. But the stock now tests resistance at ₹650. A strong break above this level will pave the way for an up-move to ₹₹685 and ₹700. A decisive rally above ₹720 will alter the downtrend and push the stock northwards to ₹750 and then to ₹775 levels.

The next key barrier is at ₹800. However, a fall below the immediate support level of ₹600 can pull the stock down to ₹575 and ₹505 levels.

Aurobindo Pharma (₹347): After a corrective medium-term uptrend, the stock of Aurobindo Pharma encountered resistance between ₹600 and ₹620 in late February, and resumed the long-term downtrend. Since then, the stock has been in a short-term downtrend. Currently, it tests a key support at ₹340. A fall below this level can pull the stock down to ₹300 and then to ₹260 over the medium term.

Conversely, a strong break above ₹400 can take the stock northwards to ₹450 and then to ₹500 in the same time frame.

Send your queries to techtrail@thehindu.co.in

Published on March 22, 2020

A letter from the Editor


Dear Readers,

The coronavirus crisis has changed the world completely in the last few months. All of us have been locked into our homes, economic activity has come to a near standstill. Everyone has been impacted.

Including your favourite business and financial newspaper. Our printing and distribution chains have been severely disrupted across the country, leaving readers without access to newspapers. Newspaper delivery agents have also been unable to service their customers because of multiple restrictions.

In these difficult times, we, at BusinessLine have been working continuously every day so that you are informed about all the developments – whether on the pandemic, on policy responses, or the impact on the world of business and finance. Our team has been working round the clock to keep track of developments so that you – the reader – gets accurate information and actionable insights so that you can protect your jobs, businesses, finances and investments.

We are trying our best to ensure the newspaper reaches your hands every day. We have also ensured that even if your paper is not delivered, you can access BusinessLine in the e-paper format – just as it appears in print. Our website and apps too, are updated every minute, so that you can access the information you want anywhere, anytime.

But all this comes at a heavy cost. As you are aware, the lockdowns have wiped out almost all our entire revenue stream. Sustaining our quality journalism has become extremely challenging. That we have managed so far is thanks to your support. I thank all our subscribers – print and digital – for your support.

I appeal to all or readers to help us navigate these challenging times and help sustain one of the truly independent and credible voices in the world of Indian journalism. Doing so is easy. You can help us enormously simply by subscribing to our digital or e-paper editions. We offer several affordable subscription plans for our website, which includes Portfolio, our investment advisory section that offers rich investment advice from our highly qualified, in-house Research Bureau, the only such team in the Indian newspaper industry.

A little help from you can make a huge difference to the cause of quality journalism!

Support Quality Journalism
This article is closed for comments.
Please Email the Editor
You have read 1 out of 3 free articles for this week. For full access, please subscribe and get unlimited access to all sections.